Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial)

Karl R. Karsch, Melitta B. Preisack, R. Baildon, Volker Eschenfelder, David P. Foley, Eulogio Garcı́a, M. Kaltenbach, Christoph Meisner, H.-K. Selbmann, Patrick W. Serruys,

Journal of the American College of Cardiology · 1996 · 122 citations · 33 references

DOIFull text

Open access

Concepts

References

33